Stay updated with breaking news from Daniel Weghuber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Austria: Semaglutide use may significantly reduce the liver enzymes indicative of liver damage, a new substudy of the STEP TEENS trial has revealed.The findings, presented at the European Congress on...
Overall, nearly half dropped below threshold for obesity
Given the positive results from the trial, the US FDA approved semaglutide for obese/overweight teenagers.
Quotable quotes heard by <em>MedPage Today</em>'s reporters
(Bloomberg) -- Novo Nordisk A/S’s weekly shot that reduces obesity in adults returned promising results in teens, according to a study that adds to a growing…